Skip to main content

Table 4 Two-dimensional and three-dimensional echocardiographic parameters measured at pre- and 6 months post-surgery

From: The impact of pericardial approach and myocardial protection onto postoperative right ventricle function reduction

Variable Pre-surgery Sixth month P Within Group
TAPSE (mm)
 Group 1 24.5 ± 4.8 14.9 ± 3 < 0.0001
 Group 2 27.4 ± 5.3 19.3 ± 4.2 0.0003
 Group 3 23.5 ± 4 21.5 ± 4.1 0.013
SPAP (mmHg)
 Group 1 33.9 ± 4.8 25.7 ± 2.9 < 0.0001
 Group 2 32.3 ± 5.1 28.3 ± 6.5 0.054
 Group 3 34.9 ± 8.1 25.2 ± 3.1 0.049
RVEDV (ml)
 Group 1 111.7 ± 42.8 93.1 ± 26.2 0.016
 Group 2 88.8 ± 26.1 72.2 ± 21.3 0.002
 Group 3 116.5 ± 19.8 105.2 ± 20.6 0.039
RVESV (ml)
 Group 1 43.4 ± 22.5 39.2 ± 13.6 0.244
 Group 2 34.7 ± 11.7 29.2 ± 9.2 0.048
 Group 3 48.5 ± 11.6 41 ± 9 0.005
3D RVEF (%)
 Group 1 62.2 ± 8.9 58.2 ± 5.4 0.021
 Group 2 60.5 ± 8.2 59.5 ± 6.9 0.579
 Group 3 58.5 ± 6.1 60.7 ± 6.8 0.207
3D RVSV (ml)
 Group 1 68.3 ± 23.9 53.9 ± 13.9 0.004
 Group 2 54.1 ± 18.8 43 ± 14.1 0.0039
 Group 3 68 ± 13.1 64.1 ± 15.9 0.349
  1. TAPSE Indicates tricuspid annular plane systolic excursion, SPAP Systolic pulmonary arterial pressure, RVEDV Right ventricular end-diastolic volume, RVESV Right ventricular end-systolic volume, RVEF Right ventricular ejection fraction, RVSV Right ventricular stroke volume